Vol.:(0123456789) 1 3
Journal of Thrombosis and Thrombolysis
https://doi.org/10.1007/s11239-018-1708-0
Residual vein obstruction in patients diagnosed with acute isolated
distal deep vein thrombosis associated with active cancer
F. Dentali
1
· S. Barco
2
· S. Pegoraro
1
· M. N. D. Di Minno
3
· D. Mastroiacovo
4
· F. Pomero
5
· C. Lodigiani
6
· F. Bagna
1
·
M. Sartori
7
· G. Barillari
8
· N. Mumoli
9
· M. Napolitano
10
· S. M. Passamonti
11
· R. Benedetti
12
· W. Ageno
1
· M. Di Nisio
13
© Springer Science+Business Media, LLC, part of Springer Nature 2018
Abstract
After acute proximal deep vein thrombosis (DVT) the thrombotic mass decreases, especially during the frst months of antico-
agulation. The persistence of residual vein obstruction (RVO) may predict future recurrence in patients with cancer-associated
DVT. We aimed to evaluate the proportion of patients with RVO after an episode of cancer associated isolated distal DVT
(IDDVT), to identify variables associated with RVO, and to provide initial evidence of its association with recurrent VTE.
We performed a post-hoc analysis of a multicenter cohort study of patients with isolated cancer-associated acute IDDVT.
We included patients who underwent a control ultrasonography at the end of the anticoagulant treatment between day 30 and
day 365 after index IDDVT, given that no recurrent VTE had already occurred on anticoagulant treatment. A total of 153
patients had ultrasonographic follow-up after a median of 92 days from index IDDVT: 45.8% had RVO and 54.2% exhibited
complete recanalization. Female sex, Body Mass Index > 30 Kg/m
2
and involvement of axial calf veins showed the strongest
association with RVO. The risk of recurrence was twofold higher in patients with (versus without) RVO. RVO persisted in
approximately half of patients with an episode of cancer-associated IDDVT at anticoagulant discontinuation. Patients with
RVO appeared to be at a higher risk for recurrent events.
Keywords Distal deep vein thrombosis · Residual vein obstruction · Compression ultrasound · Venous thromboembolism ·
Recurrence
* F. Dentali
fdentali@libero.it
1
Department of Clinical and Experimental Medicine, Insubria
University, Viale Borri 57, 21100 Varese, Italy
2
Center for Thrombosis and Hemostasis, University Medical
Center of the Johannes Gutenberg University, Mainz,
Germany
3
Unit of Cardiology, Department of Advanced Biomedical
Sciences, Federico II University, Naples, Italy
4
Angiology Unit, Avezzano Hospital, Avezzano, AQ, Italy
5
Department of Internal Medicine, S. Croce e Carle General
Hospital, Cuneo, Italy
6
Thrombosis Center, IRCCS Istituto Clinico Humanitas,
Rozzano, Milan, Italy
7
Department of Angiology and Blood Coagulation,
S. Orsola-Malpighi University Hospital, Bologna, Italy
8
Center for Haemorrhagic and Thrombotic Disorders, Udine
General and University Hospital, Udine, Italy
9
Department of Internal Medicine, Ospedale Giuseppe
Fornaroli, Magenta, Italy
10
Haemophilia and Thrombosis Center, Haematology
Department, University of Palermo, Palermo, Italy
11
A. Bianchi Bonomi Hemophilia and Thrombosis Center,
Fondazione IRCCS Ca’ Granda - Ospedale Maggiore
Policlinico, Milan, Italy
12
Haemostasis and Thrombosis Center, Department of Internal
Medicine, Hospital of Piacenza, Piacenza, Italy
13
Department of Medicine and Ageing Sciences, University
“G. D’Annunzio” of Chieti-Pescara, Chieti, Italy